Skip to main content
. 2023 Sep 19;10(6):3504–3514. doi: 10.1002/ehf2.14526

Table 3.

Association of T90 with the composite of cardiovascular death or worsening heart failure rehospitalization by Cox regression

Variable Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
T90 (<5.0 min) Reference Reference
T90 (5.0–52.0 min) 1.39 (1.08–1.79) 0.011 1.32 (1.02–1.71) 0.034
T90 (>52.0 min) 1.80 (1.41–2.30) <0.001 1.56 (1.21–2.02) 0.001
Age ≥ 60 years 1.40 (1.15–1.70) 0.001 1.20 (0.98–1.47) 0.086
BMI ≥ 28 kg/m2 0.76 (0.59–0.96) 0.022
NYHA III/IV 1.44 (1.08–1.92) 0.013
CAD 1.21 (0.99–1.48) 0.068
Hypertension 0.79 (0.65–0.96) 0.017 0.77 (0.63–0.95) 0.014
Atrial fibrillation 1.37 (1.12–1.67) 0.002
BUN, mg/dL 1.06 (1.04–1.08) <0.001 1.04 (1.01–1.06) 0.002
eGFR < 60, mL/min/1.73 m2 1.48 (1.21–1.81) <0.001
LAD, mm 1.03 (1.02–1.04) <0.001 1.03 (1.02–1.04) <0.001
LVEDD, mm 1.00 (0.99–1.01) 0.849 0.99 (0.98–1.00) 0.045
LnNT‐proBNP, pg/mL 1.43 (1.31–1.56) <0.001 1.24 (1.12–1.36) <0.001
LVEF 0.028
40–49% 0.71 (0.52–0.97) 0.031
≥50% 1.15 (0.91–1.45) 0.256
ACEIs/ARBs 0.52 (0.43–0.64) <0.001 0.66 (0.54–0.82) <0.001
Beta‐blockers 0.93 (0.66–1.33) 0.709
MRAs 0.87 (0.69–1.08) 0.866
Digoxin 1.00 (0.82–1.22) 0.998
Loop diuretics 0.89 (0.59–1.35) 0.588 0.62 (0.41–0.95) 0.028

ACEIs, angiotensin‐converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BMI, body mass index; BUN, blood urea nitrogen; CAD, coronary artery disease; CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LAD, left atrial diameter; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; MRAs, mineralocorticoid receptor antagonists; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; NYHA, New York Heart Association; T90, time < 90% oxygen saturation.